RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

I think there continues to be debate and plenty confusion in the US in regards to cannabinoids. The Australian deal makes sense financially for sure. We have not got an update there. Assuming preclinical work with the new formulations is in progress? No update on any FDA discussions or additional funding for their development path?

I think their filings for awhile have mentioned all their drug programs should be partnered/JV or sold. What happens to one of the three main platforms logically would significantly impact the other two. Maybe why everything seems to be frozen waiting for something to happen. No communications, no real trading volume or interest, no 10-k, just silence.